NorthStar Medical Radioisotopes, BWXT Medical Sign Multi-Year Master Services Agreement, Which Will Facilitate The Production Of Ac-225
Portfolio Pulse from Benzinga Newsdesk
NorthStar Medical Radioisotopes and BWXT Medical have signed a multi-year master services agreement to facilitate the production of Actinium-225 (Ac-225), a critical medical isotope used in cancer treatment.
July 22, 2024 | 11:03 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BWXT Medical has entered into a multi-year agreement with NorthStar Medical Radioisotopes to produce Actinium-225, a crucial isotope for cancer treatment.
The agreement positions BWXT Medical as a key player in the production of Ac-225, which is essential for cancer treatment. This could lead to increased revenue and market share in the medical isotope sector.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100